Alum-Formulated Glutamate Decarboxylase Injections Safe for Prediabetic Children
Time to diabetes was not significantly affected by treatment in individuals with normal or impaired glucose metabolism or by gender.
Elding Larsson H, Lundgren M, Jonsdottir B, Cuthbertson D, Krischer J; DiAPREV-IT Study Group. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: a randomized clinical trial [published online November 24, 2017]. Pediatr Diabetes. doi:10.1111/pedi.12611